Background-Adenosine can unmask dormant pulmonary vein conduction after isolation. The role of adenosine in uncovering dormant accessory pathway (AP) conduction after AP ablation is unknown. Methods and Results-We evaluated 109 consecutive patients (age, 41±28 years; 62 [57%] men) who were administered adenosine after successful AP ablation. Dormant AP conduction was defined as adenosine-induced recurrent AP conduction, as demonstrated by recurrent preexcitation or change in retrograde ventriculoatrial activation patterns. Dormant AP conduction was identified in 13 (12%) patients. Adenosine led to transient retrograde AP conduction in 6 patients and transient anterograde AP conduction in 8 patients. In all these cases, adenosine-induced AP conduction occurred during the bradycardia phase of adenosine effect and resulted in dormant AP conduction times shorter than atrioventricular nodal conduction times before adenosine administration. On the basis of analysis of timing of occurrence of dormant AP conduction, the mechanism of adenosine-induced AP conduction was determined to be caused by AP excitability recovery in ≥12 (92%) cases. The presence of dormant AP conduction was a significant predictor of chronic recurrent AP conduction requiring repeat ablation (odds ratio, 8.54; 95% confidence interval, 1.09-66.9; P=0.041). Conclusions-Adenosine can unmask dormant AP conduction after catheter ablation. Direct effects of adenosine on the AP, possibly via AP membrane potential hyperpolarization, are the dominant mechanism of adenosine-induced AP conduction after ablation. Dormant AP conduction is associated with higher rates of recurrent AP conduction requiring repeat ablation. (Circ Arrhythm Electrophysiol. 2014;7:1136-1143.)
A denosine has been used to identify the presence of dormant pulmonary vein conduction after pulmonary vein isolation. [1] [2] [3] The mechanism of this phenomenon is thought to be secondary to membrane hyperpolarization of partially depolarized cardiac tissue after ablation. 4 More recently, adenosine has also been shown to induce transient transcavotricuspid isthmus conduction after ablation of atrial flutter. 5, 6 The presence of dormant pulmonary vein and cavotricuspid isthmus conduction has been associated with increased arrhythmia recurrences after ablation. 3, 7 
Clinical Perspective on p 1143
Adenosine is also used as a diagnostic tool to assess for the presence of nondecremental accessory pathway (AP) conduction before catheter ablation, 8, 9 and the absence of AP conduction in response to adenosine after ablation has been associated with long-term elimination of AP conduction. 10 Conversely, the emergence of AP conduction with adenosine after apparently successful catheter ablation is associated with an increased recurrence of AP conduction. 11, 12 The mechanism and electrophysiological characteristics of adenosine-induced AP conduction after ablation remain to be elucidated. We therefore sought to evaluate the prevalence, characteristics, and prognostic significance of dormant conduction after successful AP ablation.
Methods

Study Population
In a retrospective analysis, we evaluated 183 consecutive patients referred for AP ablation at our institution. We excluded patients who did not undergo adenosine testing postablation (n=50), patients whose APs were not successfully ablated during the course of the procedure (n=13), patients who had undergone previous AP ablation (n=10), and patients with decremental Mahaim pathways (n=1 with atriofascicular pathway). The study was approved by the Cornell University Medical College Institutional Review Board. the operator. The following diagnostic catheters were placed: a quadripolar catheter in the right ventricle, a quadripolar catheter in the His, a decapolar catheter in the coronary sinus, and either a quadripolar catheter or a duodecapolar catheter in the right atrium. Catheter ablation was performed with either a radiofrequency ablation catheter (n=105; 4 mm EPT Blazer II; Boston Scientific, Natick, MA or Biosense Navistar; Biosense Webster) or a cryoablation catheter (n=4; 4 mm Freezor or 6 mm Freezor Xtra; Medtronic, Minneapolis; MN). The procedural end point was elimination of AP conduction.
Adenosine Testing
After successful AP ablation, adenosine was administered after a 15to 30-minute waiting period. Adenosine was given as an intravenous bolus (starting dose 12 mg) during sinus rhythm or atrial pacing to evaluate for anterograde AP and atrioventricular (AV) node conduction, and during ventricular pacing to evaluate for retrograde AP and AV node conduction. Doses of adenosine were increased (in 6-12 mg increments) as needed to ensure adequate response in the form of either AV block or sinus slowing.
Definitions
Dormant AP conduction was defined as the transient emergence of AP conduction in response to adenosine (Figure 1 ), as manifest by recurrent preexcitation or shift in retrograde concentric atrial activation, reproducing the preablation AP conduction pattern. Changes in the pre-and postablation AV interval (interval from P wave onset to QRS onset in sinus rhythm, or the interval from atrial paced stimulus spike to QRS onset if atrial paced) and the ventriculoatrial (VA) interval (ventricular pacing stimulus artifact to earliest atrial electrogram) were measured. The timing of the onset of dormant AP conduction was recorded. The onset of the bradycardia phase of adenosine effect was defined by as a 10% increase in baseline sinus cycle length and presence of AV or VA block. The offset of the bradycardia phase of adenosine effect was defined by a return to within 5% of baseline sinus cycle length and resolution of AV and VA block.
We postulated that the following 3 potential mechanisms could account for dormant AP conduction, as outlined in Figure 2 (for the sake of simplicity, the schematic diagrams refer only to dormant anterograde AP conduction, but similar principles apply to dormant retrograde AP conduction). (1) In the slow conduction model of dormant conduction (Figure 2A ), persistent slow AP conduction after ablation is present , and right ventricular apex (RVA). A, Baseline preexcitation with a P wave to delta wave interval of 97 ms. B, Postablation loss of preexcitation with a P wave to QRS onset (PR) interval of 130 ms. C, Administration of 12 mg of adenosine leads to a sinus beat with atrioventricular block, which is followed by a sinus beat with slight prolongation of PR interval to 167 ms. This is then followed by a sinus beat with preexcitation and restoration of the preablation P wave to delta wave interval of 97 ms. The occurrence of dormant AP conduction is not immediately preceded by a sinus beat with complete atrioventricular block. Abl d indicates distal ablation; Abl p, proximal ablation; and His m, middle His.
with adenosine-induced AV block unmasking AP conduction. In this model, AV and VA conduction intervals over the AP are longer than the AV and VA conduction intervals across the AV node before adenosine administration. Under these circumstances, adenosine-induced AV or VA block should not be observed because of slow persistent AP conduction, unless the persistent AP conduction is 2:1. (2) In the linking model of dormant anterograde AP conduction ( Figure 2B ), there is persistent retrograde concealment into the AP at baseline. The concealment originates from anterograde AV node conduction of the preceding sinus beat, which retrogradely activates the AP, and collides with the anterograde AP wavefront generated from the following sinus beat (linking phenomenon). In response to adenosine, there is a single beat (N-1) of simultaneous AV and AP block, with the next sinus beat (N) conducting over the AP (dormant conduction). Of note, AP block occurs with sinus beat (N-1) because of retrograde concealment into the AP after AV nodal activation from the preceding sinus beat (N-2). Therefore, the onset of dormant AP conduction in this model must be preceded by a sinus beat with complete AV block. In the linking model of dormant retrograde AP conduction, similar findings would be seen in the VA axis. (3) In the excitability recovery model of dormant AP conduction ( Figure 2C ), adenosine acts directly on AP excitability such that its conduction transiently recovers independently of adenosine's effects on the AV node. Under these circumstances, dormant AP conduction is not linked to preceding adenosine-induced AV or VA block. Dormant AP conduction intervals are equal to preablation AP conduction times if there is transient complete recovery of AP conduction, and are greater than preablation AP conduction intervals if there is transient partial recovery of AP conduction.
Follow-Up
All dates of follow-up either in the hospital or in the office after ablation were recorded. Medical records were analyzed for the presence of documentation of recurrent arrhythmias or repeat electrophysiology studies for recurrent symptoms. Clinical recurrence was defined as either recurrent supraventricular tachycardia because of recurrent AP conduction or recurrent preexcitation. For patients who had a followup electrophysiology study, the presence of recurrent AP conduction and inducible arrhythmias was recorded.
Statistical Analysis
Continuous variables are presented as mean±SD or median (quartiles: 25th percentile, 75th percentile) depending on normality of distribution. Comparison of continuous variables was performed using Student t test, whereas comparison of categorical variables was performed using the Fisher exact test. To assess whether the presence of dormant AP conduction was a predictor of chronic recurrent AP conduction, logistic regression analysis was performed. A P value of <0.05 was considered statistically significant. All statistical calculations were performed using SPSS version 19.0 (SPSS Inc, Chicago, IL). After ablation, ADO results in a single beat of AV and AP block (Beat N-1), with the subsequent sinus beat (Beat N) conducting over the AP because there is now no retrograde concealment into the AP. C, Excitability recovery model of dormant AP conduction. Adenosine acts directly on the AP to restore excitability (possibly through resting membrane hyperpolarization, independent of its effects on the AV node).
Results
Baseline Clinical and AP Characteristics
One hundred nine patients were included in the study analysis. After abolition of AP conduction by catheter ablation, a median dose of 12 mg (quartiles: 6, 36) of adenosine was administered. No adverse effects were seen with exception of induction of atrial fibrillation in 1 (1%) patient. Thirteen patients (12%) were found to have dormant AP conduction after catheter ablation (Table) . The clinical characteristics of patients with and without dormant AP conduction were similar with respect to age, sex, or cardiovascular comorbidities. A lower percentage of dormant APs had baseline retrograde conduction compared with nondormant APs (69% versus 91%; P=0.049) Other electrophysiological study findings in dormant AP and nondormant APs were similar, including the presence of baseline anterograde AP conduction, inducibility of orthodromic reciprocating tachycardia, and inducibility of atrial fibrillation.
Properties and Locations of Dormant AP Conduction
In all 13 patients with dormant AP conduction, adenosine-induced AP conduction occurred transiently during the bradycardia phase of adenosine effect. Adenosine led to dormant anterograde AP conduction in 7 patients, dormant retrograde AP conduction in 5 patients, and 1 patient with bidirectional dormant AP conduction. Adenosine led to transient complete AP conduction recovery in 9 (69%) patients and transient partial AP conduction recovery (longer AP conduction interval postablation than preablation) in 4 (31%) patients.
In all dormant APs, AP conduction intervals were shorter than postablation conduction times over the AV node before adenosine testing. Among APs with dormant anterograde conduction, the median postablation AV conduction interval (conduction over the AV node) before adenosine testing was 145 (quartiles: 121, 167) ms and the median dormant AV conduction interval was 108 (quartiles: 103, 127) ms (median decrease of 29 [quartiles: 18, 33] ms). In those with retrograde dormant APs and in whom VA conduction over the AV node was present postablation, the median postablation VA conduction interval over the AV node (before adenosine testing) was 164 (quartiles: 148, 209) ms, whereas the median dormant VA interval was 135 (quartiles: 123, 200) ms (median decrease of 29 [quartiles: 22, 37] ms). In 12 (92%) APs, adenosineinduced dormant conduction was either not immediately preceded by adenosine-induced AV or VA block (Figure 1 ) or occurred during baseline VA block (Figure 3) , consistent with adenosine-induced recovery of AP excitability. In 1 AP, adenosine-induced dormant conduction occurred immediately after the first beat of adenosine-induced VA block (Figure 4) , consistent with either a linking model or excitability recovery model of dormant AP conduction.
The locations of APs with and without dormant conduction are shown schematically in Figure 5 . A trend toward a higher proportion of para-Hisian location was seen with dormant APs compared with nondormant APs (15% versus 2%; P=0.069). All 4 patients with para-Hisian APs had undergone cryoablation. Of the 13 patients who had dormant conduction, 8 underwent additional ablation to eliminate adenosine-induced dormant AP conduction during repeat testing. In these 8 cases, ablation was performed empirically around the site of apparently successful prior AP ablation. This led to successful abolition of dormant conduction in 6 of 8 patients. The remaining 5 patients did not undergo additional ablation at the discretion of the operator.
Follow-Up
During median (quartiles: 1, 382) follow-up of 30 days, 4 (3.8%) patients had clinical recurrence and repeat electrophysiology study and ablation for recurrent AP conduction. One of the 4 patients had cryoablation at the initial procedure, whereas the remaining 3 had radiofrequency ablation. Two of the 13 patients (15%) with dormant AP conduction had repeat ablation for recurrent AP conduction compared with 2 of the 96 patients (2%) who did not have adenosine-induced transient AP conduction postablation. The presence of dormant AP conduction was a significant predictor of the need for repeat AP ablation (odds ratio, 8.55; 95% confidence interval, 1.09-66.9; P=0.041). Of note, both patients with dormant AP conduction and recurrent tachycardia had transient complete recovery of AP conduction with adenosine during their initial study. Of these, 1 patient had unsuccessful additional ablation performed to eliminate dormant conduction, whereas the other patient did not receive additional ablation. None of the 6 patients with dormant AP conduction that was successfully abolished by further ablation during their initial study required repeat ablation during follow-up. 
Table. Comparison of Demographics and Electrophysiology Study Findings of Patients With and Without Dormant Accessory Pathway Conduction
Discussion
In this study, we demonstrate that adenosine can induce transient anterograde and retrograde AP conduction (dormant conduction) after apparently successful AP ablation in 12% of patients. Dormant conduction is manifest during the bradycardia phase of adenosine effect. On the basis of our results, we conclude that nearly all (92%) dormant AP conduction seen in our study was because of adenosine-induced recovery of AP excitability. Furthermore, the presence of dormant AP conduction was associated with higher rates of repeat AP ablation, particularly in patients in whom dormant AP conduction was not successfully abolished during the initial procedure.
Mechanism of Dormant AP Conduction
Early studies examining the use of adenosine testing after ablation of APs exploited the usage of adenosines' negative dromotropic effects on the AV node to uncover preexcitation. 10 Also reported is the phenomenon of adenosine-induced AP conduction after apparently successful AP ablation [11] [12] [13] ; however, its mechanism has not been elucidated. To that end, we proposed 3 potential mechanisms for adenosine-induced AP conduction: (1) adenosine-induced AV nodal block uncovering underlying persistent but slowed AP conduction (slow conduction model; Figure 2A ); (2) adenosine-induced AV nodal block leading to abolition of concealed retrograde conduction into the AP resulting in recovery of AP conduction (linking model; Figure 2B) 9, 14 ; and (3) direct effect of adenosine on the recovery of AP conduction (excitability recovery model; Figure 2C ). In 13 of 13 (100%) patients with adenosine-induced AP conduction, conduction over the AP was shorter than preadenosine anterograde or retrograde AV nodal conduction, effectively excluding the slow AP conduction model as a mechanism of dormant conduction in our study. Furthermore, the occurrence of dormant AP conduction was not immediately preceded by adenosine-induced AV or VA nodal block in 12 APs (Figure 1) , thereby excluding the linking model in all but 1 patient. Therefore, the dominant mechanism for adenosine-induced AP conduction is mediated through a direct effect on AP conduction, one that may occur by membrane hyperpolarization. To this end, Datino et al 4 showed, in a canine model of left atrial-pulmonary vein junction ablation, that ablation results in depolarization of the tissue resting membrane potential, rendering it inexcitable secondary to sodium channel inactivation. Adenosine restores excitability in these tissues by causing hyperpolarization and sodium channel reactivation. This mechanism may also account for clinically observed adenosine-induced dormant pulmonary vein conduction 15 and transcavotricuspid isthmus conduction after ablation of atrial flutter. 5, 6 
Clinical Significance of Dormant AP Conduction
Recurrence rates of AP conduction after successful ablation are 5% to 8%. [16] [17] [18] In our study, the overall prevalence of dormant AP conduction after ablation was 12%, and its presence was associated with a higher risk of recurrent AP conduction leading to repeat ablation. Of note, among the patients with dormant AP conduction, only those whose dormant conduction was not successfully abolished with additional ablation had clinical recurrences. Previous studies reported rates of AP conduction with adenosine administration after ablation were 8.3% to 11.6%. In 1 study, all patients who had persistent , and right ventricular apex (RVA). A, During baseline ventricular pacing at a cycle length of 600 ms, earliest VA activation is recorded in the CS d with a stimulus to atrial activation interval of 144 ms. B. After ablation, retrograde VA conduction demonstrates a nodal pattern during ventricular pacing (600 ms), with stimulus to atrial (stim-A) activation time of 154 ms. C, After administration of ADO (12 mg), initial retrograde VA activation was concentric with a stim-A activation interval of 185 ms, followed by VA block for 1 beat and then 2 beats of VA conduction over the accessory pathway, which is reflected by the change in retrograde atrial activation pattern and shortening of the stim-A interval to 132 ms. This pattern is consistent with either a linking model or excitability model of dormant AP conduction. AVN indicates atrioventricular node.
adenosine-induced AP conduction despite additional ablation had clinical recurrences of AP conduction. 11 Another study showed that all patients who had ATP-induced AP conduction after ablation went on to have persistent recurrent AP conduction, although the majority of these occurred intraprocedurally before additional ablation was performed. 12 Our results are consistent with the findings from previous studies, which underscore the importance of targeting adenosine-induced AP conduction with additional ablation to reduce recurrences. Of note, we identified a trend toward a higher incidence of para-Hisian location of dormant APs where cryoablation was used exclusively. It is likely that in these cases, because of concerns of causing permanent AV block, less extensive ablation was performed leading to reduced lesion transmurality. An increased prevalence of dormant conduction at ablation sites where effective lesion delivery is challenging has also been shown after pulmonary vein isolation. 15, 19 Dormant conduction after ablation predicts recurrent conduction at various myocardial locations, including APs, pulmonary vein-left atrial junctions, and the cavotricuspid isthmus, which points to a shared mechanism with prognostic implications.
Study Limitations
There are several limitations in this study. First, the study design was retrospective in design. As such, a prospective randomized study would better address the clinical use of targeting dormant AP conduction with additional ablation. Second, the overall study population size was limited, which likely precluded finding of significant differences in the clinical and electrophysiological characteristics between patients with and without dormant conduction. Third, we proposed 3 main mechanisms for dormant AP conduction but other possible mechanisms may also be considered. Because our assessments were based on single occurrences of dormant conduction, conclusions on mechanisms may be limited. Analysis of dormant AP conduction patterns from repeated administrations of adenosine to a single patient may have allowed more definitive mechanistic conclusions. Fourth, given its transient nature, dormant conduction was not targeted systematically with additional ablation in all patients. Fifth, one cannot rule out the theoretical, albeit unlikely, possibility that in some cases, adenosine led to conduction of a separate AP that was adjacent to, but not at the precise location of, the previously ablated AP. Finally, overall follow-up times for our study patients were short and recurrence rates may have been underestimated in this study.
Conclusions
Adenosine can induce acute dormant AP conduction in 12% of patients after apparent successful AP ablation. Dormant AP conduction occurs during the bradycardia phase of adenosine effect and, in the majority of cases, it is because of a direct effect of adenosine on recovery of AP conduction. The presence of adenosine-induced AP conduction is associated with a higher risk of clinical recurrence. Additional ablation to eliminate dormant AP conduction may lead to reductions in clinical recurrences of AP conduction.
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